Prescott Group Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.41M	Hold	772,771	–	–	0.64%	44
2025 Q4	$9.55M	Hold	772,771	–	–	0.89%	21
2025 Q3	$6.82M	Hold	772,771	–	–	0.72%	29
2025 Q2	$4.93M	Buy	772,771 +145,100	+23%	+$830K	0.58%	40
2025 Q1	$3.05M	Buy	627,671 +417,671	+199%	+$3.46M	0.44%	71
2024 Q4	$2.01M	Buy	210,000 +150,000	+250%	+$1.38M	0.27%	116
2024 Q3	$501K	Buy	+60,000	New	+$545K	0.07%	199
2024 Q1	–	Sell	-853,349	Closed	-$2.05M	–	209
2023 Q4	$2.05M	Buy	853,349 +554,162	+185%	+$1.3M	0.36%	87
2023 Q3	$1.02M	Sell	299,187 -7,651	-2%	-$42.4K	0.23%	113
2023 Q2	$2.25M	Buy	+306,838	New	+$2.85M	0.49%	59
2023 Q1	–	Sell	-91,000	Closed	-$1.07M	–	176
2022 Q4	$1.07M	Buy	+91,000	New	+$1.41M	0.23%	106
2022 Q1	–	Sell	-45,693	Closed	-$1.99M	–	155
2021 Q4	$1.99M	Buy	+45,693	New	+$2.07M	0.45%	68